Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of alogliptin, once daily
(QD), combined with pioglitazone in adults with type 2 diabetes mellitus